Tridihexethyl

Profil Farmakokinetik

Waktu Paruh (Half-Life) -

Volume Distribusi -

Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

516 Data

Aclidinium	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Aclidinium.
Mianserin	Mianserin may increase the anticholinergic activities of Tridihexethyl.
Mirabegron	The risk or severity of urinary retention can be increased when Tridihexethyl is combined with Mirabegron.
Pramlintide	The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Tridihexethyl.
Secretin porcine	The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Tridihexethyl.
Tiotropium	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Tiotropium.
Topiramate	The risk or severity of hyperthermia and oligohydrosis can be increased when Tridihexethyl is combined with Topiramate.
Umeclidinium	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Umeclidinium.
Glycopyrronium	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Glycopyrronium.
Botulinum toxin type A	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Botulinum toxin type A.
Glucagon	Tridihexethyl may increase the gastrointestinal motility reducing activities of Glucagon.
Sulpiride	Tridihexethyl may increase the anticholinergic activities of Sulpiride.
Botulinum toxin type B	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Botulinum toxin type B.
Eluxadoline	The risk or severity of constipation can be increased when Tridihexethyl is combined with Eluxadoline.
Ramosetron	The risk or severity of constipation can be increased when Tridihexethyl is combined with Ramosetron.
Naltrexone	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Naltrexone.
Bezitramide	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Bezitramide.
Tramadol	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Tramadol.
Morphine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Morphine.
Codeine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Codeine.
Hydromorphone	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Hydromorphone.
Methadone	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Methadone.
Meperidine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Meperidine.
Oxycodone	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Oxycodone.
Butorphanol	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Butorphanol.
Dextropropoxyphene	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Dextropropoxyphene.
Pentazocine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Pentazocine.
Sufentanil	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Sufentanil.
Alfentanil	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Alfentanil.
Fentanyl	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Fentanyl.
Nalbuphine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Nalbuphine.
Levorphanol	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Levorphanol.
Remifentanil	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Remifentanil.
Buprenorphine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Buprenorphine.
Hydrocodone	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Hydrocodone.
Diphenoxylate	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Diphenoxylate.
Oxymorphone	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Oxymorphone.
Dezocine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Dezocine.
Levacetylmethadol	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Levacetylmethadol.
Methadyl acetate	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Methadyl acetate.
Dihydroetorphine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Dihydroetorphine.
Diamorphine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Diamorphine.
Ethylmorphine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Ethylmorphine.
Etorphine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Etorphine.
Dextromoramide	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Dextromoramide.
Desomorphine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Desomorphine.
Carfentanil	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Carfentanil.
Dihydrocodeine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Dihydrocodeine.
Alphacetylmethadol	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Alphacetylmethadol.
Dihydromorphine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Dihydromorphine.
Tapentadol	The risk or severity of urinary retention and constipation can be increased when Tridihexethyl is combined with Tapentadol.
Ketobemidone	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Ketobemidone.
DPDPE	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with DPDPE.
Lofentanil	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Lofentanil.
Opium	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Opium.
Normethadone	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Normethadone.
Piritramide	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Piritramide.
Alphaprodine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Alphaprodine.
Nicomorphine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Nicomorphine.
Meptazinol	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Meptazinol.
Phenoperidine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Phenoperidine.
Phenazocine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Phenazocine.
Tilidine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Tilidine.
Carfentanil, C-11	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Carfentanil, C-11.
Benzhydrocodone	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Benzhydrocodone.
Naloxegol	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Naloxegol.
Trospium	The risk or severity of adverse effects can be increased when Trospium is combined with Tridihexethyl.
Oxyphenonium	The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Tridihexethyl.
Benzatropine	The risk or severity of adverse effects can be increased when Benzatropine is combined with Tridihexethyl.
Disopyramide	The risk or severity of adverse effects can be increased when Disopyramide is combined with Tridihexethyl.
Metixene	The risk or severity of adverse effects can be increased when Metixene is combined with Tridihexethyl.
Terfenadine	The risk or severity of adverse effects can be increased when Terfenadine is combined with Tridihexethyl.
Buclizine	The risk or severity of adverse effects can be increased when Buclizine is combined with Tridihexethyl.
Trihexyphenidyl	The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Tridihexethyl.
Oxyphencyclimine	The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Tridihexethyl.
Procyclidine	The risk or severity of adverse effects can be increased when Procyclidine is combined with Tridihexethyl.
Hyoscyamine	The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Tridihexethyl.
Methscopolamine bromide	The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Tridihexethyl.
Darifenacin	The risk or severity of adverse effects can be increased when Darifenacin is combined with Tridihexethyl.
Anisotropine methylbromide	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Anisotropine methylbromide.
Atropine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Atropine.
Nicardipine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Nicardipine.
Mecamylamine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Mecamylamine.
Pirenzepine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Pirenzepine.
Homatropine methylbromide	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Homatropine methylbromide.
Benzquinamide	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Benzquinamide.
Propantheline	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Propantheline.
Dicyclomine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Dicyclomine.
Tropicamide	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Tropicamide.
Cocaine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Cocaine.
Quinidine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Quinidine.
Amantadine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Amantadine.
Methantheline	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Methantheline.
Cycrimine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Cycrimine.
Cyclopentolate	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Cyclopentolate.
Tolterodine	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Tolterodine.
Oxybutynin	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Oxybutynin.
Pentolinium	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Pentolinium.
Trimethaphan	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Trimethaphan.
Flavoxate	The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Flavoxate.

Target Protein

Muscarinic acetylcholine receptor M5 CHRM5

Muscarinic acetylcholine receptor M3 CHRM3

Muscarinic acetylcholine receptor M1 CHRM1

Muscarinic acetylcholine receptor M2 CHRM2

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 2

International Brands

Pathilon
Propethonum

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.

Deskripsi

Struktur Molekul 2D

Deskripsi metode visualisasi

1. Pendahuluan & Konsep

2. Sumber Data (Validasi)

3. Algoritma Visualisasi

4. Legenda Visual